Quality of Life in Patients with Metastatic or Unresectable Melanoma: Is Monotherapy with Nivolumab Preferred Over Combination Therapy?. Revista Médica de Trujillo, [S. l.], v. 19, n. 3, p. 092–097, 2024. DOI: 10.17268/rmt.2024.v19i3.6141. Disponível em: https://revistas.unitru.edu.pe/index.php/RMT/article/view/6141. Acesso em: 19 jul. 2026.